Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Aprepitant
- Therapeutic area
- Gastrointestinal & hepatology
- Drug class
- Antiemetics
- ATC
- A04
- Strength
- 125 mg
- Dosage form
- Capsule
- Pack
- 1's
- Registration no.
- 088015
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-11-11 02:59
Manufacturer
Genome Pharmaceuticals (Pvt.) Ltd.
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Repitant (Aprepitant) is used for
Aprepitant is an anti-sickness (antiemetic) medicine. It belongs to a group called NK1 receptor antagonists: it blocks a natural brain chemical (neurokinin) that sets off nausea and vomiting. It is used to prevent sickness caused by cancer chemotherapy, always together with other anti-sickness medicines. It comes as capsules, as a liquid (oral suspension) for children, and as an injection into a vein. It is prescribed by the cancer care team, and WHO includes it on its Essential Medicines List for people having chemotherapy that is strongly or moderately likely to cause sickness.
- Preventing nausea and vomiting caused by chemotherapy that is strongly or moderately likely to make people sick, such as treatment with cisplatin, cyclophosphamide, doxorubicin or epirubicin
- Preventing delayed sickness that can start some days after certain chemotherapy
- It is used together with other anti-sickness medicines, usually a steroid (dexamethasone) and a medicine such as ondansetron
- Children: the liquid is used in younger children and the capsules in teenagers, under the cancer team
- In some countries, such as the US, it is also approved to prevent sickness after surgery
Get medical help straight away if
- Get emergency help for signs of a serious allergic reaction, such as hives, rash or itching with swelling of the face or around the eyes, wheezing, or difficulty breathing or swallowing. Stop taking the capsules.
- Get urgent medical help for blistering or peeling skin, which can be a rare but severe skin reaction.
- Contact your doctor straight away for a fever with signs of infection, as chemotherapy and this medicine can lower your white blood cells.
- Contact your doctor for a fast or irregular heartbeat, painful or burning urination, or confusion or feeling disoriented.
Side effects, warnings and interactions for Aprepitant
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
About Repitant 125 mg capsule
Repitant 125 mg capsule contains Aprepitant 125 mg. It is registered with DRAP by Genome Pharmaceuticals (Pvt.) Ltd (registration no. 088015). Its official price is PKR 2,360.34 for a pack of 1's. This price has applied since 27 July 2026. Repitant is also available as 40 mg capsule and 80 mg capsule. 15 other brands of Aprepitant 125 mg (capsule) are registered in Pakistan. Compare all brands and prices →
Other strengths of Repitant
All 15 other brands of Aprepitant 125 mg capsule in Pakistan
These 15 brands are alternatives (substitutes) to Repitant: each contains Aprepitant 125 mg capsule. Ask your doctor or pharmacist before you switch brands.
Sorted by price per capsule, lowest first. The lowest is Aprep (PHARMEVO (PVT) LTD) at PKR 1,787 per capsule; the highest is Natper at PKR 2,735. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Aprep | PHARMEVO (PVT) LTD | 1's | PKR 1,787.03 | PKR 1,787 / capsule |
| Apreon | Ferozsons Laboratories Limited | 2's | PKR 3,796.72 | PKR 1,898 / capsule |
| Prometrazil | Cunningham Pharmaceuticals (Pvt.) Ltd | 2’s | PKR 4,034.02 | PKR 2,017 / capsule |
| Emvoid | Global Pharmaceuticals (Pvt.) Ltd | 2's | PKR 4,062.48 | PKR 2,031 / capsule |
| Aprichem | Next Pharmaceutical Products (Pvt.) Ltd | 2's | PKR 4,360.67 | PKR 2,180 / capsule |
| Cinvop | NAVEGAL LABORATORIES | 1 | PKR 2,335.93 | PKR 2,336 / capsule |
| Nautant | Pharmasol (Pvt) Ltd | 1's | PKR 2,335.93 | PKR 2,336 / capsule |
| Aprifarm | Farm Aid Group | 2's | PKR 4,671.86 | PKR 2,336 / capsule |
| EMEREP | AGP Limited | 2's | PKR 4,671.87 | PKR 2,336 / capsule |
| G Tant | GT Pharma Pvt. Ltd | 2's | PKR 5,211.35 | PKR 2,606 / capsule |
| Pritant | Davis Pharmaceutical Laboratories | 2's | PKR 5,212.86 | PKR 2,606 / capsule |
| Vomion | HIGH-Q Pharmaceuticals | 2's | PKR 5,212.96 | PKR 2,606 / capsule |
| Aprant | Amarant Pharmaceuticals Private Limited | 2's | PKR 5,363.00 | PKR 2,682 / capsule |
| Apritus | S.J & G. Fazul Ellahie (pvt) limited | 2's | PKR 5,363.01 | PKR 2,682 / capsule |
| Natper | M/s. Genix Pharma (Pvt) Ltd | 2's | PKR 5,470.37 | PKR 2,735 / capsule |
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Repitant, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Genome Pharmaceuticals (Pvt.) Ltd., Rawalpindi
- DRAP registration
- 088015
- Phone
- +92 51 5172521
- info@genomepharmaceuticals.com
- Website
- https://genomepharmaceuticals.com/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (1's). Current price PKR 2,360.34, effective 27 Jul 2026.
Cite this price history
MedInfoBase. Repitant 125 mg, 1's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/repitant-125-mg-088015-1s-genome-pharmaceuticals-pvt-ltd/ (accessed 11 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 2,360.34 | 2026-07-27 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 088015Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.